Institution statistics

MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH - Italy 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 49
As coordinator: 5
As participant: 43
Sole participant: 1
Coordinator / Participant Ratio: 0.12*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 16.557.192 582.375 4
2019 0 9.642.936 565.500 2
2018 0 5.552.269 0 2
2017 0 21.143.329 0 4
2016 168.277 42.884.236 0 1 2
2015 0 41.107.898 0 6
2014 0 6.799.997 0 1
2013 5.443.350 31.648.498 998.304 1 6
2012 992.666 56.348.255 1.763.609 2 9
2011 3.564.956 16.987.353 0 2 4
2010 0 16.889.532 0 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
UNIVERSITY OF HELSINKI2
AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS1
ARISTOTELIAN UNIVERSITY OF THESSALONIKI1
ASTRAZENECA1
BAYER1
BIOFYZIKALNI USTAV AKADEMIE VED CESKE REPUBLIKY1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRENDINN THERAPEUTICS BV1
BRISTOLMYERS SQUIBB COMPANY CORP1
CENTRE FEDERAL D'EXPERTISE DES SOINS DE SANTE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
DUALSYSTEMS BIOTECH1
EATRIS ERIC1
ECOLOGIC INSTITUT GEMEINNUETZIGE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ECT OEKOTOXIKOLOGIE1
EIDGENOESSISCHE ANSTALT FUER WASSERVERSORGUNG ABWASSERREINIGUNG UND GEWAESSERSCHUTZ1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELI LILLY AND COMPANY LIMITED1
ENVEX SINGLE MEMBER PC1
F HOFFMANNLA ROCHE1
FORUM DES PATIENTS EUROPEENS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GOETEBORGS UNIVERSITET1
INCONTINENTIA PIGMENTI FRANCE1
INSERM TRANSFERT1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT NATIONAL DE L ENVIRONNEMENT ET DES RISQUES INERIS1
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS1
INSTITUTE OF EXPERIMENTAL MEDICINE HUNGARIAN ACADEMY OF SCIENCES1
INSTITUTO DE SALUD CARLOS III1
ISTITUTO SUPERIORE DI SANITA1
KAROLINSKA INSTITUTE1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KLINIKUM DER UNIVERSITAET REGENSBURG1
LEIDEN UNIVERSITY1
LEUPHANA UNIVERSITAT LUNEBURG1
MASARYKOVA UNIVERZITA1
MERCK SHARP & DOHME CORP1
METABOLOMIC DISCOVERIES1
MIMETAS BV1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
NOVARTIS PHARMA1
OTTOVONGUERICKEUNIVERSITAET MAGDEBURG1
PARC SANITARI SANT JOAN DE DEU1
POLYGENE1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
SANOFIAVENTIS1
SERVICIO ANDALUZ DE SALUD1
SIMOMICS LIMITED1
SPHYNX TECHNOLOGY SOLUTIONS1
STICHTING KATHOLIEKE UNIVERSITEIT1
STICHTING VUMC1
STROKE ALLIANCE FOR EUROPE1
TEAM IT RESEARCH SL1
THE EUROPEAN MEDICINES AGENCY1
THE UNIVERSITY OF EXETER1
TMF TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV1
UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE1
UNIVERSITA DEGLI STUDI DI BRESCIA1
UNIVERSITAET BERN1
UNIVERSITAET ZU LUEBECK1
UNIVERSITAETSKLINIKUM FREIBURG1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITE DE PARIS1
UNIVERSITE DU LUXEMBOURG1
UNIVERSITY OF YORK1
VILABS1
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER1
ZEINCRO EGESZSEGUGYI SZOLGALTATO KORLATOLT FELELOSSEGU TARSASAG1
Constancy:

Total number of partners:77

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 77

Frequent / Rare Partner Ratio: 0

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-01-01Unification of treatments and Interventions for Tinnitus patients UNITIparticipant5.989.34413
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84811
2020-01-01PERsonalised MedicIne Trials PERMITparticipant2.000.00012
2019-05-01ENdoThelial macRophage Alliance In Neuroinflammation ENTRAINparticipant3.664.17420
2019-01-01An integrative strategy of testing systems for identification of EDs related to metabolic disorders OBERONparticipant5.978.76312
2018-10-01Glyco-Nanoparticles for Applications in Advance Nanomedicine NanoCarbparticipant4.052.69415
2018-05-01Laser Ablation: SElectivity and monitoRing for OPTImal tuMor removAL LASER OPTIMALparticipant1.499.5754
2017-04-01European School for Interdisciplinary Tinnitus Research ESITparticipant3.823.89712
2017-01-01Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease BBDiagparticipant3.465.70815
2017-01-01European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment ESCAPE-NETparticipant9.992.88117
2017-01-01An integrated interdisciplinary approach to animal-free chemical and nanomaterial safety assessment in3participant3.860.84319
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-09-01Chronic kidney disease and acute kidney injury – evaluation of EU and global epidemiology CKD AKIcoordinator168.2771
2016-01-01An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century EU-ToxRiskparticipant27.798.29941
2015-11-01Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project. TackSHSparticipant2.987.79412
2015-10-05Design of polyPEPTIdes diblock copolymers as emulsifiers to produce safe, controlled and reliable novel stimuli-responsive nanoCAPSules for skin care applications PEPTICAPSparticipant3.852.2949
2015-09-01a LOW environmental impact BRAke SYStem LOWBRASYSparticipant7.436.85011
2015-09-01Coordinated Research Infrastructures Building Enduring Life-science services CORBELparticipant14.837.80039
2015-05-01Novel Stromal Cell Therapy for Diabetic Kidney Disease NEPHSTROMparticipant5.994.37411
2015-05-01Secondary prEvention of CardiovascUlaR disease in the Elderly trial SECUREparticipant5.998.78611
2014-01-01Framework to respond to regulatory needs of future nanomaterials and markets FUTURENANONEEDSparticipant6.799.99725
2013-11-01Targets and biomarkers for antiepileptogenesis EPITARGETparticipant11.999.97518
2013-10-01Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe CREACTIVEcoordinator5.443.3509
2013-10-01MULTISCALE APPROACH TO THE IDENTIFICATION OF MOLECULAR BIOMARKERS IN ACUTE HEART FAILURE INDUCED BY SHOCK SHOCKOMICSparticipant5.174.00111
2013-08-01A Gateway to European Kidney Research Resources - KidneyConnect KIDNEYCONNECTparticipant499.97817
2013-02-01Heart OMics in AGEing HOMAGEparticipant12.000.00018
2013-01-01Predictive toxicology of engineered nanoparticles PRENANOTOXparticipant997.7343
2013-01-01"Modelling properties, interactions, toxicity and environmental behaviour of engineered nanoparticles" NANOPUZZLESparticipant976.8105
2012-12-01Translational research (training) in Polycystic Kidney Disease TRANCYSTparticipant2.763.7337
2012-11-01Stem-cell based therapy for kidney repair STELLARparticipant5.998.05013
2012-10-01European Consortium for High-Throughput Research in Rare Kidney Diseases EURENOMICSparticipant11.994.56728
2012-10-01A new paradigm in drug use and human health risk assessment: Sewage profiling at the community level SEWPROFparticipant4.178.23111
2012-09-01European Communication on Research Awareness Needs ECRANcoordinator892.6669
2012-06-01Search for novel molecules cross-talking between muscle and cancer with therapeutic potential against cachexia and cancer muscleandcancercoordinator100.0002
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01European Clinical Research Infrastructures Network - Integrating Activity ECRIN-IAparticipant7.999.93147
2012-01-01A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease NILVADparticipant5.999.97817
2012-01-01Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria PRIORITYparticipant5.980.50020
2012-01-01Building bridges between specialists on computational and empirical risk assessment of engineered nanomaterials NanoBRIDGESparticipant491.6005
2011-11-01Overcome failure to Publish nEgative fiNdings OPENparticipant499.99111
2011-05-01Dreaming of no more renal dialysis: how self-derived tissue and cells can replace renal function RESETparticipant2.493.0001
2011-02-01European multidisciplinary ALS network identification to cure motor neuron degeneration Euro-MOTORparticipant8.994.36215
2011-01-01Coordinating resources to assess and improve health status of migrants from Latin America COHEMIcoordinator1.999.96010
2011-01-01Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates TINN2participant5.000.00016
2011-01-01ToxBank – Supporting Integrated Data Analysis and Servicing of Alternative Testing Methods in Toxicology TOXBANKcoordinator1.564.99610
2010-08-01THE HYGIENE HYPOTHESIS : REVISITING THE CONCEPT BY INTEGRATING EPIDEMIOLOGY AND MECHANISTIC STUDIES HYGIENEparticipant2.099.9992
2010-07-01Fixed Dose Combination drugs for Secondary Cardiovascular Prevention FOCUSparticipant2.999.9999
2010-01-01Systems biology towards novel chronic kidney disease diagnosis and treatment SysKIDparticipant11.789.53429

Alias institution names:
  • ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
  • MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum